SELENIUM IN THE MAINTENANCE AND THERAPY OF HIV-INFECTED PATIENTS

被引:50
作者
SCHRAUZER, GN
SACHER, J
机构
[1] University of California, San Diego, Department of Chemistry and Biochemistry, La Jolla
[2] Große Friedberger Str.
关键词
SELENIUM; THERAPY; HIV;
D O I
10.1016/0009-2797(94)90040-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Due to its antiviral effects and its importance for all immunological functions, the administration of selenium is suggested as a supportive measure in early as well as in advanced stages of HIV-induced disease. Initial observations on the effects of selenium supplementation in HIV-infected patients indicate that selenium causes symptomatic improvements and possibly slows the course of the disease. As selenium inhibits reverse transcriptase activity in RNA-virus-infected animals, supplemental selenium could also prevent the replication of HIV and retard the development of AIDS in newly HIV-infected subjects. An adequate supply of selenium and of antioxidant vitamins is also proposed as a measure to reduce the probability of the placental transmission of HIV in pregnancy.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 33 条
  • [1] SODIUM SELENITE INHIBITION OF THE REPRODUCTION OF SOME ONCOGENIC RNA-VIRUSES
    BALANSKY, RM
    ARGIROVA, RM
    [J]. EXPERIENTIA, 1981, 37 (11): : 1194 - 1195
  • [2] BENNETT BG, 1987, SELENIUM BIOL MED B, P608
  • [3] SERUM SELENIUM CONCENTRATION AND DISEASE PROGRESS IN PATIENTS WITH HIV-INFECTION
    CIRELLI, A
    CIARDI, M
    DESIMONE, C
    SORICE, F
    GIORDANO, R
    CIARALLI, L
    COSTANTINI, S
    [J]. CLINICAL BIOCHEMISTRY, 1991, 24 (02) : 211 - 214
  • [4] DWORKIN BM, 1988, BIOL TRACE ELEM RES, V20, P86
  • [5] FAUCI AC, 1991, ANN INTERN MED, V114, P687
  • [6] Ge KY, 1987, SELENIUM BIOL MED B, P761
  • [7] KIREMIDJIANSCHU.L, 1992, 5TH INT S SEL BIOL M, P139
  • [8] SELENIUM AND IMMUNE-RESPONSES
    KIREMIDJIANSCHUMACHER, L
    STOTZKY, G
    [J]. ENVIRONMENTAL RESEARCH, 1987, 42 (02) : 277 - 303
  • [9] KOIVISTOINEN P, 1986, ANN CLIN RES, V18, P13
  • [10] KOLLER LD, 1986, CLIN EXP IMMUNOL, V63, P570